169323 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors Interleukin
RISK ASSESSMENT OF DISSEMINATED INTRAVASCULAR COAGULATION
#302IL-6 signaling and breast cancer
#303Multi-level specific targeting of cancer cells
#304Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
#305Compositions and Methods to Detect Kidney Fibrosis
#306IDENTIFICATION OF A NOVEL B CELL CYTOKINE
#307EXTRACTS FROM ARTHROSPIRA AND USES THEREOF
#308METHODS FOR DETERMINING AND MONITORING GASTROINTESTINAL INFLAMMATION
#309SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#310IL4/IL13 receptor molecule for veterinary use
#311COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#312COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#313ANTI-NR10 ANTIBODY AND USE THEREOF
#314IL-1 Binding Proteins
#315METHODS FOR TREATING IL-31-MEDIATED CONDITIONS IN COMPANION ANIMALS
#316Anti-IL-27 antibodies and uses thereof
#317CHECK POINT INHIBITION IN ORGAN FIBROSIS
#318Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
#319Target tissue-specific antigen-binding molecule
#320IL-31 dog pruritus model
#321ANTIBODIES TO IL-37
#322Decoy cytokine receptor
#323Antibodies to IL-15 and uses thereof
#324IL-13 antibody and preparation method and use thereof
#325Interleukin-31 monoclonal antibodies for veterinary use
#326Peptide vaccines against interleukin-31
#327Identification of contact lens wearers predisposed to contact lens discomfort
#328Methods and compositions related to toxicity associated with cell therapy
#329Methods of prognosis and treatment
#330Methods of treating cancer with human monoclonal antibodies against interleukin 8 (IL-8)
#331Early diagnosis of infections
#332Methods of detecting human IL-21
#333PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
#334Anti-IL-23 antibodies
#335COMPOSITIONS AND METHODS RELATING TO C5L2
#336METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS
#337Ascaroside treatment of eosinophilic esophagitis
#338Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity
#339Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
#340Therapeutic intervention for osteoporosis
#341Ascaroside treatment of autoimmune and inflammatory diseases
#342COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#343Marker for statin treatment stratification in heart failure
#344Multi-level specific targeting of cancer cells
#345Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
#346Therapeutically triggering an innate immune response in a target tissue
#347DIAGNOSIS OF CARDIOVASCULAR DISEASE
#348Method for identifying a bacterial infection
#349Protein signatures for distinguishing between bacterial and viral infections
#350Method and system for cell collection based on information regarding change over time
#351Antibody recognizing human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
#352CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody
#353Methods for detecting, diagnosing and treating ulcerative interstitial cystitis
#354IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#355BIOMARKERS
#356Interleukin-31 monoclonal antibody
#357METHODS FOR DIAGNOSIS AND TREATMENT OF SOLAR LENTIGO
#358ANTI-IL-6 RECEPTOR ANTIBODY
#359Human antibody against IL-18
#360IL-22BP AS BIOMARKER IN ANTI-TNF-ALPHA-TREATMENTS
#361Hematopoietic cell phenotyping using circulating cell-free markers
#362METHOD FOR DETECTING IMMINENT CHILDBIRTH
#363System for detecting infection in synovial fluid
#364Method for detecting basophil activation
#365Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy
#366Vagus nerve stimulation pre-screening test
#367Predicting mortality and detecting severe disease
#368METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS
#369DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#370Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3
#371IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making
#372Nucleic acid encoding antibody to human IL-1 beta
#373METHODS OF DETECTING AND QUANTIFYING IL-13 AND USES IN DIAGNOSING AND TREATING TH2-ASSOCIATED DISEASES
#374Diagnostic Test with Lateral Flow Test Strip
#375Method for diagnosing and treating fibromyalgia
#376Diagnostic methods for T cell therapy
#377Minimally-invasive measurement of esophageal inflammation
#378Identification of Biomarkers in Serum Samples Collected from Clinical Trials by Multiplex Technology
#379METHODS FOR PREDICTING RISK OF DEVELOPING HYPERTENSION
#380Compositions and methods to detect non-coeliac gluten sensitivity
#381SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR THE ORGANISM-SPECIFIC DIAGNOSIS OF SEPTICEMIA IN INFANTS
#382DEVELOPMENT OF PROGNOSTIC MARKERS DSG-3 FROM THE SALIVA OF ORAL CANCER PATIENTS
#383CONSTRUCTION METHOD OF CELL MODELS FOR DETECTING PYROGENS, CELL MODELS AND PYROGEN DETECTION KITS
#384MONOCLONAL ANTIBODIES TARGETED TO HUMAN TAXILIN ALPHA AND METHODS FOR USE OF SAME
#385Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#386Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#387DETERMINATION OF FAVORABLE DATE(S) FOR THERAPEUTIC TREATMENT DELIVERY
#388DIAGNOSTIC ASSAYS FOR SUPAR-β3 INTEGRIN DRIVEN KIDNEY DISEASES
#389Biomarkers for assessing subjects with multiple sclerosis
#390Antibody for immunoassay and method for preparing same
#391Compositions and methods for treating age-related diabetes and related disorders
#392ANTIBODIES AGAINST IL-1 BETA
#393Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers
#394Biomarkers predictive of cytokine release syndrome
#395POLYNUCLEOTIDES ENCODING MONOCLONAL ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F
#396Human monoclonal antibodies against interleukin 8 (IL-8)
#397Predicting risk of major adverse cardiac events
#398IL1RL-1 as a cardiovascular disease marker and therapeutic target
#399BIOMARKERS FOR PREDICTING A RESPONSE TO AN IMMUNOMODULATING TREATMENT IN PATIENTS WITH INFLAMMATORY DISEASE
#400ANTI-IL-17RA IMMUNOGLOBULIN SINGLE HEAVY VARIABLE DOMAIN ANTIBODIES
#401Methods of using antibodies to determine periostin levels in a sample
#402Biocompatible and bioabsorbable derivatized chitosan compositions
#403IL-11RA ANTIBODIES
#404NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
#405Therapeutic and diagnostic methods for IL-33-mediated disorders
#406Prostate cancer-associated secreted proteins
#407Methods and compositions for obtaining a tuberculosis assessment in a subject
#408METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#409Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma
#410Methods of identifying schizophrenia patients at risk for relapse
#411METHOD FOR DIAGNOSING AN INFLAMMATORY DISORDER
#412METHODS OF MODULATING CYTOKINE ACTIVITY; RELATED REAGENTS
#413IL-6 signaling and breast cancer
#414Methods for Monitoring Responsiveness to Anti-SMAD7 Therapy
#415NOVEL DESIGN OF ENZYME-LINKED IMMUNOSORBENT ASSAY PLATES AND SYSTEMS AND METHODS OF USE THEREOF
#416Human antibody specific for interleukin-1 alpha
#417IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#418Therapy
#419BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#420IL-17A binding proteins
#421METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISORDERS
#422Antibodies to human programmed death receptor PD-1
#423Methods and kits for labeling, detection and isolation of Foxp3 regulatory T cells, isolated population of Foxp3 regulatory T cells thus obtained and uses thereof
#424Method for Discriminating Symptom of Hepatic Disease
#425Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#426HOMOGENOUS AND HETEROGENEOUS ASSAYS AND SYSTEMS FOR DETERMINATION OF OCULAR BIOMARKERS
#427IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES
#428Detecting Dementia and Alzheimer's Disease Associated Biomarkers Stabilized on Solid Support Materials
#429Method for assessing protein identity and stability
#430Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#431Method for treating chronic intestinal inflammation and inflammatory bowel disease by administering antagonists of Oncostatin-M (OSM) and/or antagonists of OSM receptor-beta (OSMR)
#432Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
#433Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
#434METHOD AND DEVICE FOR QUANTIFICATION OF TARGET MOLECULES
#435METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF STROKE OR OTHER CEREBRAL INJURY
#436Biomarker for diagnosing vascular diseases and the uses thereof
#437Methods and antisera for isolating and identifying subsets of CD8 T cells
#438T CELL-BOUND CYTOKINE ASSAY FOR ANTIGEN-SPECIFIC TOLERANCE
#439Anti IL-34 antibodies
#440Human monoclonal antibodies against interleukin 8 (IL-8)
#441METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#442Methods for prediction of anti-TNFα drug levels and autoantibody formation
#443ANTI IL-36R ANTIBODIES
#444Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies
#445Anti-IL-23 antibodies, compositions, methods and uses
#446Compositions and methods for the systemic treatment of arthritis
#447METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#448SYSTEM FOR ASSESSING DRUG EFFICACY AND RESPONSE OF A PATIENT TO THERAPY
#449METHODS OF IDENTIFYING ANTIGENS FOR VACCINES
#450Biomarkers and assay to detect chronic graft versus host disease
#451Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
#452Method and panel for determining acute kidney injury
#453Human monoclonal antibodies against CD25
#454Methods and compositions for T cell generation and uses thereof
#455INHIBITION OF IL-2 PRODUCTION
#456METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#457Dual Variable Domain Immunoglobulins and Uses Thereof
#458Methods for predicting risk of developing hypertension
#459METHODS FOR PREDICTING CLINICAL OUTCOMES IN SUBJECTS AFFLICTED WITH ULCERATIVE COLITIS
#460Methods and compositions for modulating T-GM cell function
#461MONOVALENT BINDING PROTEINS
#462METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#463N-terminally truncated interleukin-38
#464METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#465TREATMENT OF LYSOSOMAL DISORDERS (IL-1 ANTAGONISTS)
#466Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
#467Methods for treating medical conditions by anti-type 2 therapy
#468Inhibition of IL-8 in the treatment of pain and/or bone loss
#469METHODS FOR ASSESSING VAGINAL ATROPHY
#470Biological marker for evaluating the IL-17 pro-inflammatory functional contribution dependent level in an individual
#471IMMUNOTHERAPEUTIC COMPOSITION, METHOD OF TREATMENT, AND METHOD OF DIAGNOSIS
#472Plasmonic substrates for metal-enhanced fluorescence based sensing, imaging and assays for cells
#473Biomarkers useful in the treatment of IL-23A related diseases
#474Diagnosis and treatment of Kawasaki disease
#475Antibodies to IL-15
#476Predicting mortality and detecting severe disease
#477METHODS AND DEVICES FOR DIAGNOSING OCULAR SURFACE INFLAMMATION AND DRY EYE DISEASE
#478Anti-IL-6 Receptor Antibody
#479Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies
#480Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
#481Polypeptide
#482Specific-binding polypeptides and uses thereof
#483USE OF INTERLEUKIN-2 FOR DIAGNOSIS OF CELIAC DISEASE
#484Diagnosis of urothelial cancer
#485TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#486Minimally-invasive measurement of esophageal inflammation
#487Method for diagnosing sleep apnea by measuring adipsin and betatrophin levels
#488METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#489IL-17F-specific capture agents, compositions, and methods of using and making
#490Method of inhibiting human IL-1 beta by administering an antibody to human IL-1 beta
#491Nucleic acid molecules encoding monoclonal antibodies specific for IL-22
#492Diagnosis of cancer by detecting dimeric IL-18
#493Compositions and methods relating to Lyme disease
#494Compositions and methods for modulating an immune response
#495SUPERANTIGEN POST-EXPOSURE THERAPY
#496Human anti-IL-32 antibodies and methods of making and using the same
#497Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis
#498CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#499Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#500CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#501TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#502METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION
#503Monoclonal antibodies that bind both IL-17A and IL-17F
#504Monoclonal antibodies which bind human periostin
#505Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
#506IL-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients
#507Antibodies to human programmed death receptor PD-1
#508Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#509IDENTIFICATION OF A NOVEL B CELL CYTOKINE
#510METHODS FOR DIAGNOSING, SCREENING, IDENTIFYING, MONITORING, AND TREATING ADVERSE LOCAL TISSUE REACTIONS, WHICH LEAD TO FAILURE OF ORTHOPEDIC IMPLANTS
#511COMPOSITIONS AND METHODS RELATING TO C5L2
#512Biocompatible and bioabsorbable derivatized chitosan compositions
#513Maternal TH17 cells and psychiatric disorders
#514Th17 differentiation markers for acne and uses thereof
#515Biomarkers related to organ function
#516Method of treating or improving neurological function in a human subject
#517Biomarkers and methods of treating PD-1 and PD-L1 related conditions
#518IL-18 binding protein (IL-18BP) in inflammatory diseases
#519Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis
#520Antibodies against IL-1 beta
#521Marker for statin treatment stratification in heart failure
#522STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#523Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#524Methods of treating pain using protein solutions
#525Biomarker for psychiatric and neurological disorders
#526Method for assessing protein identity and stability
#527Hematopoietic cell phenotyping using circulating cell-free markers
#528Highly Sensitive Biomarker Panels
#529PERSONALISED MEDICINE
#530Diagnostic biomarker to predict women at risk for preterm delivery
#531Detection of intraamniotic and/or infection
#532Interleukin-10 Compositions and Uses Thereof
#533Compositions and methods for the systemic treatment of arthritis
#534Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
#535Nanoelectronic-enzyme linked immunosorbent assay system and method
#536Aptamer to IL-17 and use thereof
#537B7-H4 fusion proteins and methods of use thereof
#538Biological specimen evaluation methods using cytology and immunology
#539Method for identifying a bacterial infection
#540PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#541Method for identifying biologically active oligonucleotides capable of modulating the immune system
#542Human antibody specific for interleukin-1alpha
#543Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
#544Method and biomarkers for the detection of dengue hemorrhagic fever
#545Methods for determining risk of chronic lung allograft dysfunction (CLAD) and subtypes thereof
#546BIOMARKERS FOR INFLAMMATORY DISEASE AND METHODS OF USING SAME
#547Method for Differentiating Sepsis and Systemic Inflammatory Response Syndrome (SIRS)
#548EFFECTOR T CELL RSISTANCE
#549Soluble human ST-2 antibodies and assays
#550Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
#551DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
#552DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-13 AND/OR IL-17
#553Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
#554METHOD FOR OBTAINING DATA THAT ARE USEFUL FOR THE DIAGNOSIS, PROGNOSIS AND CLASSIFICATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND/OR LUNG CANCER
#555Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies
#556Anti-IL-23 antibodies
#557Method for the detection of an albumin isoform
#558DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#559ANTI-INFLAMMATORY AGENTS
#560Salivary inflammatory biomarkers associated with glycemic control and oral health
#561Method for diagnosing fibromyalgia
#562METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#563Compositions and methods relating to lyme disease
#564COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS
#565Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#566Human monoclonal antibodies against CD25
#567METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA
#568VAGUS NERVE STIMULATION SCREENING TEST
#569Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#570Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients
#571ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
#572Antibodies directed to IL-17A/IL-17F heterodimers
#573Gene knock-in non-human animal
#574Use of antibodies for detection of IL-10
#575Anti IL-36R antibodies
#576Multi-level specific targeting of cancer cells
#577COMPOSITIONS AND METHODS FOR MODULATION OF IL-20 FAMILY CYTOKINE ACTIVITY
#578IN VITRO ASSAY FOR PREDICTING RENAL PROXIMAL TUBULAR CELL TOXICITY
#579BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS
#580Biomarker of renal dysfunction
#581METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#582Methods for treatment of cardiovascular disease
#583ANTI-NR10 ANTIBODY AND USE THEREOF
#584IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3
#585METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#586TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE
#587Methods For Determining Anti-TNF Therapeutic Response
#588Status of Tuberculosis Infection in an Individual
#5891L1RL-1 as a cardiovascular disease marker and therapeutic target
#590Methods and devices for tuberculosis diagnosis using biomarker profiles
#591Methods of monitoring responsiveness to anti-SMAD7 therapy
#592Treatment of acute myeloid leukemia and myelodysplastic syndromes
#593ANTIBODY RECOGNIZING HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) AND USE OF ANTI-LIF ANTIBODIES IN THE TREATMENT OF DISEASES ASSOCIATED WITH UNWANTED CELL PROLIFERATION
#594Biomarker of renal dysfunction
#595Methods of assessing the immunomodulatory potential of a multipotent stromal cell (MSC) population, and systems and kits for practicing the same
#596Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
#597Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
#598THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES
#599Genetically modified non-human animals and methods relating to innate immune system response detection
#600IL-19 AS A BIOMARKER OF TSLP TREATMENT